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1. Introduction 
Bleomycin 1s a glycopeptidlc antlblotlc used for 
the treatment of cancer [l] . In vitro, a major effect 
of bleomycm 1s the mtroduction of strand breaks into 
DNA [2,3]. Efficient breakage of DNA by bleomycm 
requues the presence of reducing agents, such as 
2-mercaptoethanol, dltiothreitol, ascorbate, or 
hydrogen peroxlde [3,4]. Although reducing agents 
alone are injurious to DNA [5,6], the combination 
ofbleomycin and a reducing agent is far more effective 
m degrading DNA than 1s either bleomycin or 
reducmg agent alone [7,8] Limted damage to DNA 
may be observed with tigh concentrations of
bleomycm alone [8,9]. 
Since bleomycin binds to DNA 111 the absence of 
added reducmg agents [lo] , the role of the latter 
compounds has recently been studied in detail. It 
has been established that Fe(I1) can substitute for the 
reducmg agents to effectively degrade DNA [ 111. 
Bleomycm and Fe(H) together were far more 
efficient m cleaving DNA than either species alone. 
This result has been venfied [ 121. It was suggested 
[ 121, but no convmcing evidence was provided, that 
hydroxyl radical may be responsible for bleomycin- 
induced damage to DNA. 
Fe(II1) cannot replace Fe(H) m the degradation of
DNA by bleomycm m the absence of reducmg agent, 
but III the presence of reducing agent, either Fe(I1) or 
FE(II1) greatly stimulates DNA degradation by 
bleomycin [ 1 l] . Metal chelators and other metal ions 
mhiblt DNA degradation [ 131. Superoxide radical 
(0,~) stimulates DNA degradation by bleomycm 
[13,14]. These observations have led to the proposal 
of the followmg model for the action of bleomycin 
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[ 131. Bleomycin can bmd to DNA m the absence of 
metal ion or reducing agent. Fe(I1) can then attach to 
the bleomycin and thus form a ternary complex. This 
ternary complex can then form the species which 
degrades DNA. Reducing agents enhance the reaction 
by regeneratmg Fe(I1) from Fe(III) and thus con- 
tmumg the reaction. Superoxide radical also generates 
Fe(H) from Fe(III) [ 15,161. However, this model 
does not identify the nature of the toxic species. 
Since this proposed mechanism was sirmlar to that 
observed [ 16-181 for the production of hydroxyl 
radical (‘OH) from xanthine-xanthine oxidase, we 
thought his radical might also be responsible for the 
degradation of DNA by bleomycm. We report here 
the use of the technique of spin trappmg [191 to 
determine the Identity of the species produced by 
bleomycln. The spin trapping technique involves the 
addition reaction of a short-lived free radical to a 
compound, spin trap, to produce a relatively long 
lived free radical product, spin adduct, whch is 
easily studied by electron spin resonance (ESR). The 
hyperfme splitting observed enables one m many 
cases to make a positive identification of the species 
trapped. Using this technique, we have observed that 
bleomycm and Fe(I1) produce the ‘OH spin adduct. 
2. Materials and methods 
2.1. Reagents 
Bleomycm was obtained from Bristol Laboratories 
and dissolved in &stilled water immediately prior to 
use. FeS04 and FeC13 were obtained from Fisher 
Scientific. The spin trap 5,5dimethyl-l-pyrroline-l- 
oxide (DMPO) was purchased from Aldnch Chermcal 
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Co. The colored impurity was removed by filtratron 
with decolorizmg charcoal using -10 parts water to 
1 part DMPO. The purified DMPO solutron was frozen 
untrl used. 
2.2. Methods 
All additions were made to 50 mM potassmm 
phosphate buffer (pH 7.8). All reaction mixtures con- 
tained -100 mM DMPO. Solutions m an aqueous 
sample cell were placed m an electron spm resonance 
spectrometer (Varian, E-4) cavity, and their spectra 
obtamed using standard procedures. 
3. Results 
DMPO, 100 mM m potassium phosphate buffer, 
produced no srgnal. When either 160 I.~M bleomycm 
(250 Kg/ml) or 130 MM FeSOdFe(I1)) was added to 
the buffer plus 100 mM DMPO, no srgnal was 
observed. When 160 PM bleomycin, 100 mM DMPO, 
and 100 I.~M Fe(H) was added to the buffer, the 
signal shown m fig. 1 appeared. The spectrum is 
essentrally Identical to that identified [20] as the 
hydroxyl spin adduct of DMPO. When the same 
experiment 1s carned out with Fe(II1) as FeCla, no 
signal results. EDTA, 33 PM, abolished the signal, 
whrle 90 PM HzOz enhanced the signal by a factor of 
-10. The latter observatrons are consistent with those 
in [13]. 
i 
ioGnuss 
Frg.1. ESR spectra of the hydroxyl spin adduct produced by 
bleomycin and Fe(D) usmg DMPO as the spin trap. The 
reaction mixture contained 160 PM bleomycm, 100 mM 
DMPO, and 100 PM FeSO, in 50 mM potassium phosphate 
buffer (pH 7.8). The spectral properties are identical to those 
found in [20] for the hydroxyl spin adduct. 
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4. Discussion 
Our results agree with those m [ 131 and support 
then model. Fe(I1) apparently binds to bleomycm 
and produces an oxygen-dependent radical. We have 
identified thrs radical as ‘OH, the most powerful 
oxrdizing radical known to arise in brological systems. 
Reducing agents, such as Hz02, either produce ‘OH 
directly from the reaction between Hz O2 and Fe(I1) 
(Fenton’s reagent), or convert Fe(II1) to Fe(I1). 
This result is analogous to our findings m the 
xanthine-xanthrne oxrdase system [161. In this 
system, iron or an non-EDTA complex reacts with 
superoxrde. 
Fe(II1) + 0; + Fe(I1) t O2 
HzOz t Fe(I1) + Fe(III) + OH- + ‘OH 
Bleomycrn evidently reacts with Fe(H) m a similar 
manner, although EDTA can block this reaction and 
not the reaction of Fe(H) and HzOz . 
Smce bleomycin binds preferentially to DNA, the 
net result is that we have a ‘site-specific free radical’ 
as proposed [21] for the antitumor action of 
qumone antibiotics. This release of free radicals in 
close proximity to DNA 1s necessary because of the 
high reactivity of ‘OH. Its rate constants are so large 
for most compounds that it wrll react with the first 
molecule it encounters. Thus, m order to damage 
DNA, it must be released close to it. 
As noted earlier, reducing agents uch as H,O? 
or Oz- are necessary for bleomycin to effectively 
degrade DNA. The question arises Where 1s the 
source of this reducmg agent m the tumor cell? We 
have recently reported greatly diminrshed amounts of 
manganese uperoxide drsmutase in tumor cells 
[22,23]. Others have also seen tlus loss of manganese 
superoxrde dismutase [24,25]. Cu-Zn superoxide 
drsmutase 1s also reduced m many tumors [26]. Thrs 
decrease m enzyme activity would result in greatly 
Increased levels of 02- in the mitochondria. It has 
been shown that a- can easily pass through cell 
membranes [27]. Thus, superoxide produced 111 the 
mitochondna may be able to diffuse to the nucleus. 
Moreover, O*- has recently been shown to be 
produced m tumor cell nuclei [28] . The increased 
levels of &- m tumor cells as compared to normal 
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cells may explain the differential toxlclty exhibited 
between ormal and malignant cells upon treatment 
with bleomycm. 
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